As of March 26, we're $27,100 in the red for the quarter. Donate here to support this vital work
Subscribe here and join over 13,000 subscribers to our free weekly newsletter

Psychedelic drugs may be ready for a medical comeback
Key Excerpts from Article on Website of Los Angeles Times


Los Angeles Times, September 8, 2015
Posted: September 27th, 2015
http://www.latimes.com/science/sciencenow/la-sci-sn-psychede...

New research on the use of psychedelic drugs as treatment for a range of mental disorders appears to be throwing open doors of perception long closed within the medical community, says a new analysis in the Canadian Medical Assn. Journal. For several decades, the North American medical establishment has classified psychedelic drugs – including LSD, psilocybin and [MDMA, better known as ecstasy] – as drugs of abuse with little to no medical purpose or means of safe use. That, four researchers argue, is changing. In Switzerland, Canada, Brazil, Peru, Mexico and the United States, researchers with no evident countercultural tendencies are conducting research that is finding psychedelic drugs a valuable adjunct to psychotherapy in treating addiction, post-traumatic stress and the depression or anxiety that often comes with terminal illness. Clinical investigators are demonstrating that such research "can conform to the rigorous scientific, ethical and safety standards expected of contemporary medical research," the authors write in the new analysis, titled "Psychedelic medicine: a re-emerging therapeutic paradigm." And the body of research they are generating is demonstrating that such drugs as MDMA, LSD and psilocybin can be effective in treating well-chosen patients. Two other factors - cost and time - also appear to be opening minds about the potential therapeutic uses of psychedelic drugs.

Note: For more about the therapeutic uses of psychedelic drugs, see these concise summaries of deeply revealing news articles from reliable sources.


Latest News


Key News Articles from Years Past